Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer (Q39591068)
Jump to navigation
Jump to search
scientific article published on 18 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer |
scientific article published on 18 July 2016 |
Statements
1 reference
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer (English)
1 reference
Sung-Bae Kim
1 reference
Hans Wildiers
1 reference
Ian E Krop
1 reference
Melanie Smitt
1 reference
Ron Yu
1 reference
Sanne Lysbet de Haas
1 reference
Antonio Gonzalez-Martin
1 reference
18 July 2016
1 reference
1 reference
2336-2342
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference